264 related articles for article (PubMed ID: 32352602)
1. Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation.
Yang Y; He X; Cheng R; Chen Q; Shan C; Chen L; Ma JX
FASEB J; 2020 Jun; 34(6):8428-8441. PubMed ID: 32352602
[TBL] [Abstract][Full Text] [Related]
2. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.
Yiu WH; Wong DW; Wu HJ; Li RX; Yam I; Chan LY; Leung JC; Lan HY; Lai KN; Tang SC
Kidney Int; 2016 Feb; 89(2):386-98. PubMed ID: 26536000
[TBL] [Abstract][Full Text] [Related]
3. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
4. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
[TBL] [Abstract][Full Text] [Related]
5. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload.
Chaudhary K; Chilakala A; Ananth S; Mandala A; Veeranan-Karmegam R; Powell FL; Ganapathy V; Gnana-Prakasam JP
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F512-F517. PubMed ID: 31188032
[TBL] [Abstract][Full Text] [Related]
6. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.
Lian H; Cheng Y; Wu X
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696221
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
[TBL] [Abstract][Full Text] [Related]
10. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
He X; Cheng R; Park K; Benyajati S; Moiseyev G; Sun C; Olson LE; Yang Y; Eby BK; Lau K; Ma JX
Kidney Int; 2017 Mar; 91(3):642-657. PubMed ID: 27914705
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
13. A novel mouse model of advanced diabetic kidney disease.
Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis Enhanced Diabetic Renal Tubular Injury
Feng X; Wang S; Sun Z; Dong H; Yu H; Huang M; Gao X
Front Endocrinol (Lausanne); 2021; 12():626390. PubMed ID: 33679620
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
[TBL] [Abstract][Full Text] [Related]
16. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
17. Renal kallikrein activation and renoprotection after dual blockade of renin-angiotensin system in diet-induced diabetic nephropathy.
Zou X; Zhang XX; Liu XY; Li R; Wang M; Wu WJ; Sui Y; Zhao HL
J Diabetes Res; 2015; 2015():310645. PubMed ID: 25918729
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
19. A protective role of renalase in diabetic nephropathy.
Yin J; Liu X; Zhao T; Liang R; Wu R; Zhang F; Kong Y; Liu L; Xing T; Wang N; Zhao Q; Wang F
Clin Sci (Lond); 2020 Jan; 134(1):75-85. PubMed ID: 31899483
[TBL] [Abstract][Full Text] [Related]
20. Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.
Kobori H; Kamiyama M; Harrison-Bernard LM; Navar LG
J Investig Med; 2013 Feb; 61(2):256-64. PubMed ID: 23266706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
